Jane Street’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Jane Street’s Portfolio YARW Stock Details YARW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$57.1K	Buy	1,913 +466	+32%	+$13.6K	﹤0.01%	10916
2025 Q4	$42K	Sell	1,447 -1,495	-51%	-$30K	﹤0.01%	10556
2025 Q3	$49.3K	Buy	2,942 +446	+18%	+$14.6K	﹤0.01%	10358
2025 Q2	$206K	Buy	+2,496	New	+$162K	﹤0.01%	8494
2025 Q1	–	Sell	-406	Closed	-$68K	–	10738
2024 Q4	$68K	Buy	+406	New	+$53.1K	﹤0.01%	8889
2023 Q1	–	Sell	-21	Closed	-$2.77K	–	10025
2022 Q4	$2.77K	Sell	21 -35	-63%	-$6.99K	﹤0.01%	8916
2022 Q3	$11K	Buy	+56	New	+$17.9K	﹤0.01%	9328
2022 Q2	–	Sell	-13	Closed	-$8K	–	11022
2022 Q1	$8K	Sell	13 -15	-54%	-$8.91K	﹤0.01%	10097
2021 Q4	$26K	Buy	+28	New	+$30K	﹤0.01%	9732
2021 Q2	–	Sell	-19	Closed	-$115K	–	10488
2021 Q1	$115K	Buy	+19	New	+$138K	﹤0.01%	8582
2020 Q4	–	Sell	-27	Closed	-$164K	–	8181
2020 Q3	$164K	Buy	27 +3	+13%	+$17.5K	﹤0.01%	6547
2020 Q2	$148K	Buy	24 +10	+71%	+$67.7K	﹤0.01%	6560
2020 Q1	$132K	Buy	+14	New	+$220K	﹤0.01%	4823

Other funds holding YARW

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

T3 Companies New York $93.7M AUM

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KCA

KVP Capital Advisors San Francisco, California $134M AUM

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Jane Street's YARW Position: Q1 2026 in Review

Jane Street increased its Yarrow Bioscience, Inc. Common Stock (YARW) stake by 32% in Q1 2026, buying an estimated $13.6K and bringing the position to 1,913 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #10916.

Jane Street first reported a position in YARW in Q1 2020 and has held it in 13 quarters since. The position peaked at $206K in Q2 2025. 42 funds tracked by Wall St. Rank hold YARW as of Q1 2026.

Jane Street held 1,913 shares of Yarrow Bioscience, Inc. Common Stock worth $57.1K as of Q1 2026.
Jane Street bought 466 Yarrow Bioscience, Inc. Common Stock shares in Q1 2026, an estimated $13.6K.
Yarrow Bioscience, Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10916 holding.
Jane Street first reported a position in Yarrow Bioscience, Inc. Common Stock in Q1 2020 and has held it in 13 quarters since.
Jane Street's Yarrow Bioscience, Inc. Common Stock position peaked at $206K in Q2 2025.
42 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.